Hyaluronic acid treatment for osteoarthritis of the knee

Nurse Practitioner

Volumn 24, Issue 7, 1999, Pages 38-49

  Leslie, Maryann ^a  

^a UNIVERSITY OF NORTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HYALURONIC ACID;

HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KNEE OSTEOARTHRITIS; NURSING; REVIEW;

ANTI-INFLAMMATORY AGENTS; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, KNEE;

EID: 0033159279     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-199907000-00005     Document Type: Article

References (32)

1. Centers for Disease Control anti Prevention: Factors associated with prevalent self-reported arthritis and other rheumatic conditions-United States, 1989-1991. MMWR 1996;48(23):487-491.
2. George E, Creamer P, Dieppe PA: Clinical subsets of osteoarthritis. J Mus- culoskel Med 1994; 11(2): 14-10.
3. Brandt KD: Osteoarthritis. In: Isselhacher KJ, Hraunwald E, Wilson JD, et al., eds. Harrison Principles of Internal Medicine, 13th edition. New York, N.Y.: McGraw-Hill, 1994:1692-98.
4. Davis MA, Ettinger WH Neuhaus JM: Knee osteoarthritis and physical functioning: Evidence from the NHANES1 epidemiologic follow-up study. J Rheumatol 1991;18:591-98.
5. Fclson DT, Neimark A, Anderson J, et al.: The prevalence of knee osteoarthritis in the elderly: 'Hie Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914-18.
6. Neyret P, Donell ST, Dejour D, et al.: Partial meniscectomy and anterior cruciate ligament rupture in soccer players: A study with a minimum 20- year follow-up. Am J Sports Med 1993;21:455-60.
7. Lane NE: Exercise: A cause of ostcuartltrids.J Rheumatol 1995;22(suppl 43): 3-6.
8. Lane NE, Beat M, Bjorkengren A, et al.: The risk of osteoarthritis with runningand aging: A 5-year longitudinal study. J Rheumatol 1993;20:461-68.
9. Kerrigan DC, Todd MK, O Riley P: Knee osteoarthritis ami high-heeled shoes. Lancet 1998;351:1399-1401.
10. Felson DT, Anderson JJ, Naimark A, et al.: Obesity and knee osteoarthritis: 'I’he Framingham Study. Ann Intern Med 1988;109:18-24.
11. Moskowit, Rw: Treatment of osteoarthritis. Paper presented at the eighth manual Cleveland Review of Rheumatic Diseases, Cleveland, Ohio, May 1998.
12. Fife RS: Osteoarthritis: Epidemiology, pathology and pathogenesis. In: KlippelJI I, ed. Primer on the Rheumatic Diseases, 11th edition. Atlanta, Ga.: Arthritis Foundation, 1997;216-17.
13. Knudson YV, Kuettner KE: Proteoglycans. In Klippel JH, ed. Primer on the Rheumatic Diseases, 11th edition. Atlanta, CJa.: Arthritis Foundation, 1997;33-38.
14. Brandt KD: Diagnosis and Nonsurgical Management of Osteoarthritis. Caddo, Okla: Professional Communications, l996;45-47.
15. Brandt KD: Diagnosis and Nonsurgical Management of Osteoarthritis. Caddo, Okla.: Professional Communications, 196 162.
16. Peyron JG: Intra-articular hyaluronan injections in the treatment of osteoarthritis: State-of-the-art review.J Rheumatol 1993;20(suppl 39):10-15.
17. I lochherg MC: Osteoarthritis: Clinical features an l treatment. In: Klippel JM, ed. Primer on the Rheumatic Diseases, Uth edition. Atlanta, Ga.: Arthritis Foundation, 1997;218-21.
18. Creamer P, I lochherg MC: The relationship between psychosocial variables and pain reporting in osteoarthritis of the knee. Arthritis Care Res 1998(1l(l)):60-68.
19. Flemming DJ, Murphy MD: Osteoarthritis: A guide to roentgenographic findings. J Musculoskcl Med 1997;11(9):15-25.
20. Felson DT: Nonmedicinal therapies for osteoarthritis. Hull Rheum Dis 1998;47(2):5-7.
21. Regeski wJ, Ettinger YVH, Martin K, et al.: Treating disability in knee osteoarthritis with exercise therapy: A central role for self-efficacy and pain. Arthritis Care Res 1998; 1(2)100-101.
22. I lochhcrg MC, Altman RD, Brandt KD, et al.: Guidelines for the medical management of osteoarthritis: Part II. Osteoarthritis of the knee. Arthritis Rheum 1995;38(11): 1541-46.
23. Muller-Fabender I I, Bach GL, Haase IV, et al.: Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cart 1994; 2:61-69.
24. Noack V, Fischer M, Forster KK, et al.: Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cart 1994;2:51-59.
25. Corrado EM, Pcluso GF, Gigliotti S, et al.: The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: A clinical study with immunological and biochemical evaluations. Euro j Rheumatol Inflamm 1995; 15(1):21-31.
26. Tlyalgan (Sodium hyaluronatc). Package Insert. New York, N.Y.: Sanofi Pharmaceuticals, 1997.
27. Altman RD, Moskowitz R, and the I-Iyaliaria Study Group: A placebo and naproxen controlled study of intra-articular hyaluronatc in osteoarthritis of the knee. Arthritis Rheum 1995;38(suppl 2-10): 1-30.
28. Listrat V, Avral X, Patarnello F, et al.: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Ostcoarthrits Cart 1997;5:153-60.
29. Synvisc (Mylan G-F 20). l’ackage Insert. Philadelphia, Pa.: Wyeth Laboratories, 1997.
30. Adams MF, Atkinson M, Lussler Al, et al.: Comparison of intra-articular hyalgan G-F (Synvisc), a viscoelastic derivative of hyaluronan, and continuous NSA1D therapy in patients with ostcoarchritis of the knee. Arthritis Rheum 1993;37(suppl (65)):12-20.
31. Scale D, YVobig M, YVolpert YV: Viscosupplcmentation of osteoarthritis of the knees with Mylan: A treatment schedule study. Curr 'Flier Res 1994; 55:220-32.
32. Health Care Financing Administration. Hylan polymers for osteoarthritis of the knee: New medical policy. In: Medicare Newsletter. Columbus, Ohio: Nationwide Insurance Enterprise, 1998;5.